News details

Apr 5, 2019

Royal DSM and Lallemand conclude license agreement

Pess Release
Elgin, Illinois (USA) and Toronto (Canada)
5 April 2019


Royal DSM and Lallemand Inc. are pleased to announce a joint agreement under which DSM grants to
Lallemand a non-exclusive, royalty bearing license to DSM’s low-glycerol yeast technology patents (U.S.
Patent No. 8,795,998). The license agreement is part of a settlement that was reached following a 2018
US Federal Court jury verdict in Wisconsin. The referenced technology in the agreement is for use in the
fermentation of first-generation biofuels.


DSM – Bright Science. Brighter Living.™

Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable
Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some
of the world’s biggest challenges while simultaneously creating economic, environmental and societal
value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers
innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices,
green products and applications, and new mobility and connectivity. DSM and its associated companies
deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was
founded in 1902 and is listed on Euronext Amsterdam. More information can be found at



Lallemand is a privately owned company specializing in the research, development, production, marketing
and distribution of yeast, bacteria and other microorganisms for use in the food ingredient, human
nutrition, animal nutrition, baking, wine, beer, distilled spirits, biofuels, plant care, cosmetic and
pharmaceutical industries. Lallemand has approximately 4,000 employees located in more than 40
countries, on all continents. More information can be found at

For a copy of this press release, see here